|
Re: Not adding up!
|
3
|
Zenith Epigenetics
|
Nov 15, 2021 01:46PM
|
|
Re: Volume
|
3
|
Zenith Epigenetics
|
Apr 13, 2021 09:31AM
|
|
Re: What impact would a PR like this have?
|
3
|
Resverlogix Corp.
|
Jan 29, 2019 05:45PM
|
|
Re: Shot interest jumps big....
|
3
|
Resverlogix Corp.
|
Feb 03, 2017 11:21PM
|
|
Re: Merck's PIII Prostate trial, not the one with ZEN-3694, is halted for not showing improvement vs control
|
3
|
Zenith Epigenetics
|
Jan 27, 2023 02:47PM
|
|
Re: Bioasis Announces Publication of CNS Delivery of siRNA via xB³ ™ Platform Technology
|
3
|
BIOASIS TECHNOLOGIES INC
|
Mar 29, 2021 05:33PM
|
|
Re: https://themarkether...
|
3
|
Resverlogix Corp.
|
Feb 23, 2022 12:47PM
|
|
Re: Meh....beatching is fun
|
3
|
Resverlogix Corp.
|
Aug 05, 2016 05:58PM
|
|
Re: Disagree
|
3
|
BIOASIS TECHNOLOGIES INC
|
Jul 19, 2021 03:17PM
|
|
Re: Not adding up!
|
3
|
Zenith Epigenetics
|
Nov 15, 2021 02:21PM
|
|
Re: An invitation to join the conversation here on Agoracom
|
3
|
BIOASIS TECHNOLOGIES INC
|
Jun 22, 2018 08:25PM
|
|
Re: yawn...
|
3
|
BIOASIS TECHNOLOGIES INC
|
Aug 17, 2021 08:47PM
|
|
Re: New Interim Financials and MD&A docs on SEDAR
|
3
|
Resverlogix Corp.
|
Dec 17, 2015 11:30AM
|
|
Re: New trial
|
3
|
Zenith Epigenetics
|
May 25, 2021 10:36PM
|
|
Re: AGM - Jan 7, 2016 - Details
|
3
|
Zenith Epigenetics
|
Jan 08, 2016 11:24AM
|
|
Re: Additional Exempt Distribution- 2023-03-31
|
3
|
Zenith Epigenetics
|
Apr 12, 2023 12:38PM
|
|
XB³-001
|
3
|
BIOASIS TECHNOLOGIES INC
|
Jun 30, 2020 10:00AM
|
|
Re: TD Zenith Capital Corp | Grey Market : ZHCLF
|
3
|
Zenith Epigenetics
|
Jul 17, 2020 11:47AM
|
|
Re: New trial
|
3
|
Zenith Epigenetics
|
May 28, 2021 11:12PM
|
|
Re: Why I think it's a homerun
|
3
|
Resverlogix Corp.
|
Mar 03, 2019 08:51PM
|
